Stephen F. Mahoney
President and CEO · Viridian Therapeutics, Inc.\DE
Individual
- 2026
- Mar 9, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen F. Mahoney files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $30.00M in VRDN purchases and sales in the last 12 months
- Jennifer Tousignant - $419K in VRDN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen F. Mahoney?
Stephen F. Mahoney is a corporate insider, tracked as President and CEO of Viridian Therapeutics, Inc.\DE (VRDN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Stephen F. Mahoney last file a Form 4?
The most recent primary Form 4 on record is dated 9 March 2026, one of 2 filings going back to 2026.
